In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of over 2,000 clinically approved drugs on DNA repair and CRISPR genome editing outcomes. They found compounds that can be used to improve genome editing, molecules that selectively kill cultured cancer cells, and further identified novel roles in DNA repair for two proteins.